Gault, Victor A.

Novel GLP‐1 mimetics developed to treat type 2 diabetes promote progenitor cell proliferation in the brain

Hamilton, A., Patterson, S., Porter, D., Gault, V. A., & Holscher, C. (2011) · Journal of Neuroscience Research

Neurogenesis and neuroplasticity mechanismsDiabetes Treatment and Management

Cited by 210

Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: A link between diabetes and Alzheimer's disease

McClean, P. L., Gault, V. A., Harriott, P., & Hölscher, C. (2010) · European Journal of Pharmacology

Alzheimer's disease research and treatmentsNeuroscience and Neuropharmacology Research

Cited by 193

Administration of an acylated GLP-1 and GIP preparation provides added beneficial glucose-lowering and insulinotropic actions over single incretins in mice with Type 2 diabetes and obesity

Gault, V. A., Kerr, B. D., Harriott, P., & Flatt, P. R. (2011) · Clinical Science

Diabetes Treatment and ManagementPancreatic function and diabetes

Cited by 125

A novel glucagon-like peptide-1 (GLP-1)/Glucagon hybrid peptide with triple-acting agonist activity at glucose-dependent insulinotropic polypeptide, GLP-1, and glucagon receptors and therapeutic potential in high fat-fed mice

Gault, V. A., Bhat, V. K., Irwin, N., & Flatt, P. R. (2013) · Journal of Biological Chemistry

Diabetes Treatment and ManagementPancreatic function and diabetes

Cited by 123

Structurally Modified Analogues of Glucagon-Like Peptide-1 (GLP-1) and Glucose-Dependent Insulinotropic Polypeptide (GIP) As Future Antidiabetic Agents

Green, B., Gault, V., O'Harte, F., & Flatt, P. (2004) · Current Pharmaceutical Design

Diabetes Treatment and ManagementPancreatic function and diabetes

Cited by 111

A novel acylated form of (d-Ala2)GIP with improved antidiabetic potential, lacking effect on body fat stores

Martin, C. M. A., Irwin, N., Flatt, P. R., & Gault, V. A. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects

Diabetes Treatment and ManagementPancreatic function and diabetes

Cited by 53

Lixisenatide improves recognition memory and exerts neuroprotective actions in high-fat fed mice

Lennox, R., Flatt, P. R., & Gault, V. A. (2014) · Peptides

Diabetes Treatment and ManagementNeurogenesis and neuroplasticity mechanisms

Cited by 47

A neuronal circuit driven by GLP-1 in the olfactory bulb regulates insulin secretion

Montaner, M., Denom, J., Simon, V., Jiang, W., Holt, M. K., Brierley, D. I., Rouch, C., Foppen, E., Kassis, N., Jarriault, D., et al. (2024) · Nature Communications

Pancreatic function and diabetesRegulation of Appetite and Obesity

Cited by 36

Blockade of gastric inhibitory polypeptide (GIP) action as a novel means of countering insulin resistance in the treatment of obesity-diabetes

Irwin, N., Gault, V. A., O’Harte, F. P. M., & Flatt, P. R. (2020) · Peptides

Adipokines, Inflammation, and Metabolic DiseasesRegulation of Appetite and Obesity

Cited by 27